The epidemiology of musculoskeletal infections

Orthopaedic Knowledge Update: Musculoskeletal Infection

Volumn , Issue , 2018, Pages 3-14

  Esterhai, John L ^a   Rao, Nalini ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85059157352     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (43)

1. Burke JP: Infection control: A problem for patient safety. N Engl J Med 2003;348: 651-656.
2. Anderson DJ, Sexton DJ, Kanafani ZA, Auten G, Kaye KS: Severe surgical site infection in community hospitals: Epidemiology, key procedures, and the changing prevalence of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2007;28: 1047-1053.
3. Patel M, Weinheimer JD, Waites KB, Baddley JW: Active surveillance to determine the impact of methicillin resistant Staphylococcus aureus colonization on patients in the intensive care unit of a Veterans Administration Medical Center. Infect Control Hosp Epidemiol 2008;29: 503-509.
4. US Department of Health and Human Services: Hospital Compare. http://www.hospitalcompare.hhs.gov. Updated February 11, 2009. Accessed March 4, 2009. Hospital reporting of SCIP measures is disclosed to the public on this Web site.
5. Centers for Medicare and Medicaid Services: QualityNet. http://qualitynet.org. Accessed January 30, 2009.
6. Harris JA: Infection control in pediatric extended care facilities. Infect Control Hosp Epidemiol 2006;27: 598-603.
7. Rohr U, Wilhelm M, Muhr G, Gatermann S: Qualitative and (semi)quantitative characterization of nasal and skin methicillin-resistant Staphylococcus aureus carriage of hospitalized patients. Int J Hyg Environ Health 2004;207: 51-55.
8. Milstone AM, Perl TM: MRSA: Screening and laboratory identification. Pediatr Infect Dis J 2008;27: 927-928.
9. McGarry SA, Engemann JJ, Schmader K, Sexton DJ, Kaye KS: Surgical site infections due to Staphylococcus aureus among elderly patients: Mortality, duration of hospitalization and cost. Infect Control Hosp Epidemiol 2004;25: 461-467.
10. Fishman JA: Infection in solid organ transplant recipients. N Engl J Med 2007;357: 2601-2614.
11. Siegel JD, Rhinehart E, Jackson M, Chiarello L, Healthcare Infection Control Practices Advisory Committee: Management of Multidrug-Resistant Organisms in Healthcare Settings, 2006. Atlanta, GA: Centers for Disease Control and Prevention, 2006. http://www.cdc.gov/ncidod/dhqp/pdf/ar/mdroguideline2006.pdf. Accessed January 26, 2009.
12. Grundmann H, Aires-de-Sousa M, Boyce J, Tiemersma E: Emergence and resurgence of methicillin-resistant Staphylococcus aureus as a public health threat. Lancet 2006;368: 874-885.
13. Engemann JJ, Carmeli Y, Cosgrove SE, et al: Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 2003;36: 592-598.
14. Klein E, Smith DL, Laxminarayan R: Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005. Emerg Infect Dis 2007;13: 1840-1846.
15. Moellering RC Jr : Vancomycin: A 50-year reassessment. Clin Infect Dis 2006;42: S3-S4.
16. Klevens RM, Morrison MA, Nadle J, et al: Invasive methicillin resistant Staphylococcus aureus infections in the United States. JAMA 2007;298: 1763-1771.
17. Diep BA, Chambers HF, Graber CJ, et al: Emergence of multi-drug resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 2008;148: 249-257.
18. Daum RS: Clinical practice: Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med 2007;357: 380-390.
19. Gould IM: Community-acquired MRSA: Can we control it? Lancet 2006;368: 824-826.
20. Paintsil E: Pediatric community acquired methicillin-resistant Staphylococcus aureus infection and colonization: Trends and management. Curr Opin Pediatr 2007;19: 75-82.
21. Levine DP: Vancomycin: A history. Clin Infect Dis 2006;42: S5-S12.
22. Centers for Disease Control and Prevention: Campaign to Prevent Antimicrobial Resistance in Healthcare Settings: 12 steps to prevent antimicrobial resistance among hospitalized adults. http://www.cdc.gov/drugresistance/healthcare/ha/12steps_HA.htm. Published November 2003. Accessed March 4, 2009.
23. Carroll KC: Rapid diagnostics for methicillin resistant Staphylococcus aureus: Current status. Mol Diagn Ther 2008;12: 15-24.
24. Griffith ME, Gonzalez RS, Holcomb JB, Hospenthal DR, Wortmann GW, Murray CK: Factors associated with recovery of Acinetobacter baumannii in a combat support hospital. Infect Control Hosp Epidemiol 2008;29: 664-666.
25. Zapor MJ, Erwin D, Erowele G, Wortman G: Emergence of multidrug resistance in bacteria and impact on antibiotic expenditure at a major army medical center caring for soldiers wounded in Iraq and Afghanistan. Infect Control Hosp Epidemiol 2008;29: 661-663.
26. Do AN, Ciesielski CA, Metler RP, Hammett TA, Li J, Fleming PL: Occupationally acquired human immunodeficiency virus (HIV) infection: National case surveillance data during 20 years of the HIV epidemic in the United States. Infect Control Hosp Epidemiol 2003;23: 86-96.
27. Solomon SL: Updated US public health guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR 2005;54: RR-9. http://www.cdc.gov/mmwr/PDF/rr/rr5409.pdf. Accessed February 9, 2009.
28. Rao N: Septic arthritis. Curr Treat Options Infect Dis 2002;4: 279-287.
29. Smith JW, Chalupa P, Shabaz Hasan M: Infectious arthritis: Clinical features, laboratory findings and treatment. Clin Microbiol Infect 2006;12: 309-314.
30. Garcia-De La Torre I: Advances in the management of septic arthritis. Rheum Dis Clin North Am 2003;29: 61-75.
31. Ross JJ: Septic arthritis. Infect Dis Clin North Am 2005;19: 799-817.
32. Calhoun JH, Manring MM: Adult osteomyelitis. Infect Dis Clin North Am 2005;19: 765-786.
33. Calhoun JH, Rao N, Manring MM: Osteomyelitis. Epocrates Online. https://online.epocrates.com/u/2911354/Osteomyelitis. Updated August 5, 2008. Accessed March 4, 2009.
34. Zimmerli W: Infection and musculoskeletal conditions: Prosthetic-joint-associated infections. Best Pract Res Clin Rheumatol 2006;20: 1045-1063.
35. Zimmerli W, Trampuz A, Ochsner PE: Prosthetic-joint infections. N Engl J Med 2004;351: 1645-1654.
36. Lidgren L, Knutson K, Stefansdottir A: Infection and arthritis: Infection of prosthetic joints. Best Pract Res Clin Rheumatol 2003;17: 209-218.
37. Govender S: Spinal infections. J Bone Joint Surg Br 2005;87: 1454-1458.
38. Jevtic V: Vertebral infection. Eur Radiol 2004;14: E43-E52.
39. Tali ET, Gultekin S: Spinal infections. Eur Radiol 2005;15: 599-607.
40. Jeffcoate WJ, Harding KG: Diabetic foot ulcers. Lancet 2003;361: 1545-1551.
41. Boulton AJM: The diabetic foot: Grand overview, epidemiology and pathogenesis. Diabetes Metab Res Rev 2008;24: S3-S6.
42. Lipsky BA, Berendt AR, Deery HG, et al: Diagnosis and treatment of diabetic foot infections. Clin Infect Dis 2004;39: 885-910.
43. Rao N, Lipsky BA: Optimizing antimicrobial therapy in diabetic foot infections. Drugs 2007;67: 196-214.